Cargando…
Design, synthesis and evaluation of 3-phenoxypyrazine-2-carboxamide derivatives as potent TGR5 agonists
TGR5 is emerging as an important and promising target for the treatment of non-alcoholic steatohepatitis, type 2 diabetes mellitus (T2DM), and obesity. A series of novel 3-phenoxypyrazine-2-carboxamide derivatives were designed, synthesized and evaluated in vitro and in vivo. The most potent compoun...
Autores principales: | Zhao, Shizhen, Wang, Le, Wang, Jie, Wang, Chenwei, Zheng, Shaowei, Fu, Yajie, Li, Yunfu, Chen, Wei-Dong, Hou, Ruifang, Yang, Dongbin, Wang, Yan-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979340/ https://www.ncbi.nlm.nih.gov/pubmed/35425398 http://dx.doi.org/10.1039/d1ra08867j |
Ejemplares similares
-
Ligand-based pharmacophore modeling, virtual screening and biological evaluation to identify novel TGR5 agonists
por: Zhao, Shizhen, et al.
Publicado: (2021) -
Pharmacophore modeling and virtual screening studies for discovery of novel farnesoid X receptor (FXR) agonists
por: Zhao, Shizhen, et al.
Publicado: (2021) -
TGR5, Not Only a Metabolic Regulator
por: Guo, Cong, et al.
Publicado: (2016) -
TGR5 agonists induce peripheral and central hypersensitivity to bladder distension
por: Caldwell, Ashlee, et al.
Publicado: (2022) -
Design and Synthesis of 4-(Heterocyclic Substituted Amino)-1H-Pyrazole-3-Carboxamide Derivatives and Their Potent Activity against Acute Myeloid Leukemia (AML)
por: Zhi, Yanle, et al.
Publicado: (2019)